Senna Tabs
- Product NDC
- 16103-363
- 11-digit product format
- 161030363
- Labeler code
- 16103
- Product ID
- 16103-363_61f99f78-d945-4004-a167-f3a80979f4a4
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Senna
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Pharbest Pharmaceuticals, Inc.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2018-09-03
- Substance
- SENNOSIDES A AND B
- Active strength
- 8.6 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 16103-363-08 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 16103-363-11 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 16103-363-08 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 16103-363-11 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Senna Tabs
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES A AND B | 8.6 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1B5FPI42EN | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 312935 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b9f8ea59-932f-4827-a87c-b4aff909c43f | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 16103-363-08 | 2024-12-31 | Drug Facts |
| 16103-363-11 | 2024-12-31 | Drug Facts |
| 16103-363-08 | 2023-01-30 | Drug Facts |
| 16103-363-11 | 2023-01-30 | Drug Facts |
| 16103-363-08 | 2021-03-27 | Drug Facts |
| 16103-363-11 | 2021-03-27 | Drug Facts |
| 16103-363-08 | 2020-01-31 | Drug Facts |
| 16103-363-11 | 2020-01-31 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16103-363-08 | Senna Tabs | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 4 | |
| 16103-363-11 | Senna Tabs | 1000 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 1000 | 4 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16103-363-08 | EA - Each | 16103-363 | d1c46bcd-5c41-4cf5-a0d1-def0b83c46da | 1 | 2012-07-24 |
| 16103-363-11 | EA - Each | 16103-363 | 52f694b3-25f1-401c-a42d-b8750a77e2a6 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stratuscare Glycerin Laxative Pediatric | GLYCERIN | Stratus Pharmaceuticals | 6ae6d3c4-bb3b-4436-b76d-8654bf871e66 | 2024-11-01 | Warnings | M007 |
| Rite Aid Fiber Therapy | METHYLCELLULOSE | RITE AID CORPORATION | e50cea80-c020-4b85-b61f-d053f11f479b | 2024-10-30 | Warnings | M007 |
| Rite Aid Fiber Caplets | CALCIUM POLYCARBOPHIL | RITE AID CORPORATION | 06e46cb0-2928-479e-984d-2305fff995e0 | 2024-10-30 | Warnings | M007 |
| Premier Value Orange Flavor | PSYLLIUM HUSK | PHARMACY VALUE ALLIANCE, LLC | 2d580965-2bef-46ee-8532-fbe34330a4b4 | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber Therapy | METHYLCELLULOSE | PHARMACY VALUE ALLIANCE, LLC | b875d5f8-02f3-4474-9fda-83091bc7de04 | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber Therapy Original Coarse | PSYLLIUM HUSK | PHARMACY VALUE ALLIANCE, LLC | 8c85a13d-ae99-4599-9a28-c3965caa6376 | 2024-10-28 | Warnings | M007 |
| Premier Value | CALCIUM POLYCARBOPHIL | PHARMACY VALUE ALLIANCE, LLC | 4d766548-00d0-41bd-bb58-b69e037c77e2 | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber | PSYLLIUM HUSK | Chain Drug Consortium, LLC | c507fe4a-1f8e-4780-a2f5-9da6e5922bef | 2024-10-28 | Warnings | M007 |
| Premier Value Fiber Therapy Orange Flavor | PSYLLIUM HUSK | PHARMACY VALUE ALLIANCE, LLC | 85651bd7-e959-4455-a5ed-bd0223ce0563 | 2024-10-28 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM AND SENNOSIDES | BETTER LIVING BRANDS LLC. | f2c61c71-9a23-4bd3-e053-2a95a90ad460 | 2024-10-26 | Warnings | M007 |
| Pedia-Lax | GLYCERIN | C.B. Fleet Company, Inc. | ae367381-7146-4307-823d-2bb44c1d4200 | 2024-10-25 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Target Corporation | f7309f4a-f1f5-420e-bfc7-fb4495a5afba | 2024-10-24 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Target Corporation | 2540ae39-2218-0f6a-e063-6294a90a5efc | 2024-10-24 | Warnings | M007 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Sam's West Inc | b0e99ebb-41fc-459f-86d2-f0e3527f97b0 | 2024-10-24 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | A-S Medication Solutions | ef05ad45-7082-43e6-9533-a79c5aa0f373 | 2024-10-22 | Warnings | M007 |
| Bliss GVS Children | GLYCERIN | Bliss GVS Pharma Limited | 03237ed2-265f-4acd-b504-d82b9263287c | 2024-10-17 | Warnings | M007 |
| NATURAL Epsom Salt | MAGNESIUM SULFATE | Universal Distribution Center LLC | b2682e51-ffa4-4556-b2a6-b0dbd543fd4f | 2024-10-16 | Warnings | M007 |
| Bliss GVS | GLYCERIN | Bliss GVS Pharma Limited | 1a3982a1-9ce9-4a1a-ba73-ebe2d8647109 | 2024-10-10 | Warnings | M007 |
| Bisacodyl | BISACODYL | Padagis US LLC | 7eada0fc-5f83-43da-a56f-b0f537298208 | 2024-10-10 | Warnings | M007 |
| exchange select stool softener | DOCUSATE SODIUM | Army & Air Force Exchange Service | 14985848-d791-42b9-ad7e-810a85bb1ee1 | 2024-10-07 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312935 | sennosides 8.6 MG Oral Tablet | PSN | 2b03d07c-ea4f-4663-bcc3-20ebdf83b7aa | 9 |
| 312935 | sennosides, USP 8.6 MG Oral Tablet | SCD | 2b03d07c-ea4f-4663-bcc3-20ebdf83b7aa | 9 |
| 312935 | sennosides A and B 8.6 MG Oral Tablet | SY | 2b03d07c-ea4f-4663-bcc3-20ebdf83b7aa | 9 |
| 312935 | sennosides 8.6 MG Oral Tablet | PSN | b9f8ea59-932f-4827-a87c-b4aff909c43f | 4 |
| 312935 | sennosides, USP 8.6 MG Oral Tablet | SCD | b9f8ea59-932f-4827-a87c-b4aff909c43f | 4 |
| 312935 | sennosides A and B 8.6 MG Oral Tablet | SY | b9f8ea59-932f-4827-a87c-b4aff909c43f | 4 |
| 312935 | sennosides 8.6 MG Oral Tablet | PSN | cd6e3fb4-0c5a-4aa7-89ea-109c6d072efe | 3 |
| 312935 | sennosides, USP 8.6 MG Oral Tablet | SCD | cd6e3fb4-0c5a-4aa7-89ea-109c6d072efe | 3 |
| 312935 | sennosides A and B 8.6 MG Oral Tablet | SY | cd6e3fb4-0c5a-4aa7-89ea-109c6d072efe | 3 |
| 312935 | sennosides 8.6 MG Oral Tablet | PSN | bcf5bc3f-60c8-bfd7-e053-2a95a90a97a7 | 1 |
| 312935 | sennosides, USP 8.6 MG Oral Tablet | SCD | bcf5bc3f-60c8-bfd7-e053-2a95a90a97a7 | 1 |
| 312935 | sennosides A and B 8.6 MG Oral Tablet | SY | bcf5bc3f-60c8-bfd7-e053-2a95a90a97a7 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 16103-363-08 | 16103036308 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16103-363-08) | 2018-09-03 | 0000-00-00 | No | No | Current |
| 16103-363-11 | 16103036311 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (16103-363-11) | 2018-09-03 | 0000-00-00 | No | No | Current |